δ-Tocopherol Inhibits Receptor Tyrosine Kinase-Induced AKT Activation in Prostate Cancer Cells

The cancer preventive activity of vitamin E is suggested by epidemiological studies and supported by animal studies with vitamin E forms, g-tocopherol and delta-tocopherol (delta-T). Several recent large-scale cancer prevention trials with high dose of a-tocopherol, however, yielded disappointing results. Whether vitamin E prevents or promotes cancer is a serious concern. A better understanding of the molecular mechanisms of action of the different forms of tocopherols would enhance our understanding of this topic. In this study, we demonstrated that delta-T was the most effective tocopherol form in inhibiting prostate cancer cell growth, by inducing cell cycle arrest and apoptosis. By profiling the effects of delta-T on the cell signaling using the phospho-kinase array, we found that the most inhibited target was the phosphorylation of AKT on T308. Further study on the activation of AKT by EGFR and IGFR revealed that delta-T attenuated the EGF/IGF-induced activation of AKT (via the phosphorylation of AKT on T308 induced by the activation of PIK3). Expression of dominant active PIK3 and AKT in prostate cancer cell line DU145 in which PIK3, AKT, and PTEN are wild type caused the cells to be reflectory to the inhibition of delta-T, supporting that delta-T inhibits the PIK3-mediated activation of AKT. Our data also suggest that delta-T interferes with the EGF-induced EGFR internalization, which leads to the inhibition of the receptor tyrosine kinase-dependent activation of AKT. In summary, our results revealed a novel mechanism of delta-T in inhibiting prostate cancer cell growth, supporting the cancer preventive activity delta-T. (C) 2015 Wiley Periodicals, Inc.